Uncategorized

Woolsey Pharmaceuticals Begins ALS Study

PRESS RELEASE NEW YORK, December 13, 2021 — Woolsey Pharmaceuticals, a clinical-stage company developing treatments for neurodegenerative diseases, today announced it